Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.

Identifieur interne : 000037 ( Hal/Checkpoint ); précédent : 000036; suivant : 000038

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.

Auteurs : David Devos [France] ; Kathy Dujardin ; Isabelle Poirot ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre

Source :

RBID : Hal:hal-00336977

Abstract

Depression is one of the most common psychiatric disturbances in Parkinson's disease (PD). Recent reviews have highlighted the lack of controlled trials and the ensuing difficulty in formulating recommendations for antidepressant use in PD. We sought to establish whether antidepressants provide real benefits and whether tricyclic and selective serotonin reuptake inhibitor (SSRI) antidepressants differ in their short-term efficacy, because the time to onset of therapeutic benefit remains an important criterion in depression. The short-term efficacy (after 14 and 30 days) of two antidepressants (desipramine, a predominantly noradrenergic reuptake inhibitor tricyclic and citalopram, a SSRI) was assessed in a double-blind, randomized, placebo- controlled study of 48 nondemented PD patients suffering from major depression. After 14 days, desipramine prompted an improvement in the Montgomery Asberg Depression Rating Scale (MADRS) score, compared with citalopram and placebo. Both antidepressants produced significant improvements in the MADRS score after 30 days. Mild adverse events were twice as frequent in the desipramine group as in the other groups. A predominantly noradrenergic tricyclic antidepressant induced a more intense short-term effect on parkinsonian depression than did an SSRI. However, desipramine's lower tolerability may outweigh its slight short-term clinical advantage.

Url:
DOI: 10.1002/mds.21966

Links toward previous steps (curation, corpus...)


Links to Exploration step

Hal:hal-00336977

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.</title>
<author>
<name sortKey="Devos, David" sort="Devos, David" uniqKey="Devos D" first="David" last="Devos">David Devos</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-1296" status="VALID">
<orgName>Institut d'électronique, de microélectronique et de nanotechnologie</orgName>
<orgName type="acronym">IEMN</orgName>
<desc>
<address>
<addrLine>avenue Poincaré, Cité scientifique, BP 69, 59652 Villeneuve d'Ascq cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.iemn.univ-lille1.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-300066" type="direct"></relation>
<relation active="#struct-300279" type="direct"></relation>
<relation active="#struct-300996" type="direct"></relation>
<relation name="UMR8520" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300066" type="direct">
<org type="institution" xml:id="struct-300066" status="VALID">
<orgName>Institut supérieur de l'électronique et du nunérique (ISEN)</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300279" type="direct">
<org type="institution" xml:id="struct-300279" status="VALID">
<orgName>Université de Valenciennes et du Hainaut-Cambresis</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300996" type="direct">
<org type="institution" xml:id="struct-300996" status="INCOMING">
<orgName>Université Lille 1 - Sciences et technologies</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle name="UMR8520" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name>
</author>
<author>
<name sortKey="Poirot, Isabelle" sort="Poirot, Isabelle" uniqKey="Poirot I" first="Isabelle" last="Poirot">Isabelle Poirot</name>
</author>
<author>
<name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-94723" status="VALID">
<orgName>Noyaux gris centraux</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300070" type="direct"></relation>
<relation active="#struct-300996" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300070" type="direct">
<org type="institution" xml:id="struct-300070" status="VALID">
<orgName>CHRU Lille</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300996" type="direct">
<org type="institution" xml:id="struct-300996" status="INCOMING">
<orgName>Université Lille 1 - Sciences et technologies</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Cottencin, Olivier" sort="Cottencin, Olivier" uniqKey="Cottencin O" first="Olivier" last="Cottencin">Olivier Cottencin</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-11323" status="VALID">
<orgName>Laboratoire de Neurosciences Fonctionnelles et Pathologies</orgName>
<orgName type="acronym">LNFP</orgName>
<desc>
<address>
<addrLine>Service EFV Hôpital Roger Salengro CHRU Lille 59037 Lille Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://LNFP.dr18.cnrs.fr</ref>
</desc>
<listRelation>
<relation active="#struct-300277" type="direct"></relation>
<relation name="UMR8160" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300277" type="direct">
<org type="institution" xml:id="struct-300277" status="VALID">
<orgName>Université Lille II - Droit et santé</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle name="UMR8160" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Thomas, Pierre" sort="Thomas, Pierre" uniqKey="Thomas P" first="Pierre" last="Thomas">Pierre Thomas</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-11323" status="VALID">
<orgName>Laboratoire de Neurosciences Fonctionnelles et Pathologies</orgName>
<orgName type="acronym">LNFP</orgName>
<desc>
<address>
<addrLine>Service EFV Hôpital Roger Salengro CHRU Lille 59037 Lille Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://LNFP.dr18.cnrs.fr</ref>
</desc>
<listRelation>
<relation active="#struct-300277" type="direct"></relation>
<relation name="UMR8160" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300277" type="direct">
<org type="institution" xml:id="struct-300277" status="VALID">
<orgName>Université Lille II - Droit et santé</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle name="UMR8160" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Destee, Alain" sort="Destee, Alain" uniqKey="Destee A" first="Alain" last="Destée">Alain Destée</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-58976" status="INCOMING">
<orgName>Clinique Neurologique</orgName>
<desc>
<address>
<addrLine>Lille</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300070" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300070" type="direct">
<org type="institution" xml:id="struct-300070" status="VALID">
<orgName>CHRU Lille</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bordet, Regis" sort="Bordet, Regis" uniqKey="Bordet R" first="Regis" last="Bordet">Regis Bordet</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2775" status="VALID">
<orgName>Institut de médecine predictive et de recherche thérapeutique</orgName>
<orgName type="acronym">IMPRT</orgName>
<desc>
<address>
<addrLine>Faculte de Medecine 1, Place de Verdun 59045 LILLE CEDEX</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation name="IFR114" active="#struct-300002" type="direct"></relation>
<relation active="#struct-300070" type="direct"></relation>
<relation active="#struct-300166" type="direct"></relation>
<relation active="#struct-300277" type="direct"></relation>
<relation active="#struct-301886" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="IFR114" active="#struct-300002" type="direct">
<org type="institution" xml:id="struct-300002" status="VALID">
<orgName>INSERM</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300070" type="direct">
<org type="institution" xml:id="struct-300070" status="VALID">
<orgName>CHRU Lille</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300166" type="direct">
<org type="institution" xml:id="struct-300166" status="VALID">
<orgName>Institut Pasteur de Lille</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300277" type="direct">
<org type="institution" xml:id="struct-300277" status="VALID">
<orgName>Université Lille II - Droit et santé</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-301886" type="direct">
<org type="institution" xml:id="struct-301886" status="VALID">
<orgName>CRLCC Oscar Lambret</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-00336977</idno>
<idno type="halId">hal-00336977</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-00336977</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-00336977</idno>
<idno type="doi">10.1002/mds.21966</idno>
<date when="2008-04-30">2008-04-30</date>
<idno type="wicri:Area/Hal/Corpus">000016</idno>
<idno type="wicri:Area/Hal/Curation">000016</idno>
<idno type="wicri:Area/Hal/Checkpoint">000037</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.</title>
<author>
<name sortKey="Devos, David" sort="Devos, David" uniqKey="Devos D" first="David" last="Devos">David Devos</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-1296" status="VALID">
<orgName>Institut d'électronique, de microélectronique et de nanotechnologie</orgName>
<orgName type="acronym">IEMN</orgName>
<desc>
<address>
<addrLine>avenue Poincaré, Cité scientifique, BP 69, 59652 Villeneuve d'Ascq cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.iemn.univ-lille1.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-300066" type="direct"></relation>
<relation active="#struct-300279" type="direct"></relation>
<relation active="#struct-300996" type="direct"></relation>
<relation name="UMR8520" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300066" type="direct">
<org type="institution" xml:id="struct-300066" status="VALID">
<orgName>Institut supérieur de l'électronique et du nunérique (ISEN)</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300279" type="direct">
<org type="institution" xml:id="struct-300279" status="VALID">
<orgName>Université de Valenciennes et du Hainaut-Cambresis</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300996" type="direct">
<org type="institution" xml:id="struct-300996" status="INCOMING">
<orgName>Université Lille 1 - Sciences et technologies</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle name="UMR8520" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name>
</author>
<author>
<name sortKey="Poirot, Isabelle" sort="Poirot, Isabelle" uniqKey="Poirot I" first="Isabelle" last="Poirot">Isabelle Poirot</name>
</author>
<author>
<name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-94723" status="VALID">
<orgName>Noyaux gris centraux</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300070" type="direct"></relation>
<relation active="#struct-300996" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300070" type="direct">
<org type="institution" xml:id="struct-300070" status="VALID">
<orgName>CHRU Lille</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300996" type="direct">
<org type="institution" xml:id="struct-300996" status="INCOMING">
<orgName>Université Lille 1 - Sciences et technologies</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Cottencin, Olivier" sort="Cottencin, Olivier" uniqKey="Cottencin O" first="Olivier" last="Cottencin">Olivier Cottencin</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-11323" status="VALID">
<orgName>Laboratoire de Neurosciences Fonctionnelles et Pathologies</orgName>
<orgName type="acronym">LNFP</orgName>
<desc>
<address>
<addrLine>Service EFV Hôpital Roger Salengro CHRU Lille 59037 Lille Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://LNFP.dr18.cnrs.fr</ref>
</desc>
<listRelation>
<relation active="#struct-300277" type="direct"></relation>
<relation name="UMR8160" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300277" type="direct">
<org type="institution" xml:id="struct-300277" status="VALID">
<orgName>Université Lille II - Droit et santé</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle name="UMR8160" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Thomas, Pierre" sort="Thomas, Pierre" uniqKey="Thomas P" first="Pierre" last="Thomas">Pierre Thomas</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-11323" status="VALID">
<orgName>Laboratoire de Neurosciences Fonctionnelles et Pathologies</orgName>
<orgName type="acronym">LNFP</orgName>
<desc>
<address>
<addrLine>Service EFV Hôpital Roger Salengro CHRU Lille 59037 Lille Cedex</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://LNFP.dr18.cnrs.fr</ref>
</desc>
<listRelation>
<relation active="#struct-300277" type="direct"></relation>
<relation name="UMR8160" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300277" type="direct">
<org type="institution" xml:id="struct-300277" status="VALID">
<orgName>Université Lille II - Droit et santé</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle name="UMR8160" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Destee, Alain" sort="Destee, Alain" uniqKey="Destee A" first="Alain" last="Destée">Alain Destée</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-58976" status="INCOMING">
<orgName>Clinique Neurologique</orgName>
<desc>
<address>
<addrLine>Lille</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300070" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300070" type="direct">
<org type="institution" xml:id="struct-300070" status="VALID">
<orgName>CHRU Lille</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bordet, Regis" sort="Bordet, Regis" uniqKey="Bordet R" first="Regis" last="Bordet">Regis Bordet</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2775" status="VALID">
<orgName>Institut de médecine predictive et de recherche thérapeutique</orgName>
<orgName type="acronym">IMPRT</orgName>
<desc>
<address>
<addrLine>Faculte de Medecine 1, Place de Verdun 59045 LILLE CEDEX</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation name="IFR114" active="#struct-300002" type="direct"></relation>
<relation active="#struct-300070" type="direct"></relation>
<relation active="#struct-300166" type="direct"></relation>
<relation active="#struct-300277" type="direct"></relation>
<relation active="#struct-301886" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="IFR114" active="#struct-300002" type="direct">
<org type="institution" xml:id="struct-300002" status="VALID">
<orgName>INSERM</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300070" type="direct">
<org type="institution" xml:id="struct-300070" status="VALID">
<orgName>CHRU Lille</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300166" type="direct">
<org type="institution" xml:id="struct-300166" status="VALID">
<orgName>Institut Pasteur de Lille</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300277" type="direct">
<org type="institution" xml:id="struct-300277" status="VALID">
<orgName>Université Lille II - Droit et santé</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-301886" type="direct">
<org type="institution" xml:id="struct-301886" status="VALID">
<orgName>CRLCC Oscar Lambret</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name>
</author>
</analytic>
<idno type="DOI">10.1002/mds.21966</idno>
<series>
<title level="j">Movement Disorders</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date type="datePub">2008-04-30</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Depression is one of the most common psychiatric disturbances in Parkinson's disease (PD). Recent reviews have highlighted the lack of controlled trials and the ensuing difficulty in formulating recommendations for antidepressant use in PD. We sought to establish whether antidepressants provide real benefits and whether tricyclic and selective serotonin reuptake inhibitor (SSRI) antidepressants differ in their short-term efficacy, because the time to onset of therapeutic benefit remains an important criterion in depression. The short-term efficacy (after 14 and 30 days) of two antidepressants (desipramine, a predominantly noradrenergic reuptake inhibitor tricyclic and citalopram, a SSRI) was assessed in a double-blind, randomized, placebo- controlled study of 48 nondemented PD patients suffering from major depression. After 14 days, desipramine prompted an improvement in the Montgomery Asberg Depression Rating Scale (MADRS) score, compared with citalopram and placebo. Both antidepressants produced significant improvements in the MADRS score after 30 days. Mild adverse events were twice as frequent in the desipramine group as in the other groups. A predominantly noradrenergic tricyclic antidepressant induced a more intense short-term effect on parkinsonian depression than did an SSRI. However, desipramine's lower tolerability may outweigh its slight short-term clinical advantage.</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.</title>
<author role="aut">
<persName>
<forename type="first">David</forename>
<surname>Devos</surname>
</persName>
<email></email>
<idno type="halauthor">365640</idno>
<affiliation ref="#struct-1296"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Kathy</forename>
<surname>Dujardin</surname>
</persName>
<email></email>
<idno type="halauthor">365641</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Isabelle</forename>
<surname>Poirot</surname>
</persName>
<email></email>
<idno type="halauthor">365642</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Caroline</forename>
<forename type="middle">C.</forename>
<surname>Moreau</surname>
</persName>
<email></email>
<idno type="halauthor">113337</idno>
<affiliation ref="#struct-94723"></affiliation>
<affiliation ref="#struct-581"></affiliation>
<affiliation ref="#struct-11037"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Olivier</forename>
<surname>Cottencin</surname>
</persName>
<email></email>
<idno type="halauthor">362835</idno>
<affiliation ref="#struct-11323"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Pierre</forename>
<surname>Thomas</surname>
</persName>
<email></email>
<idno type="halauthor">165345</idno>
<affiliation ref="#struct-11323"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Alain</forename>
<surname>Destée</surname>
</persName>
<email></email>
<idno type="halauthor">365643</idno>
<affiliation ref="#struct-58976"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Regis</forename>
<surname>Bordet</surname>
</persName>
<email></email>
<idno type="halauthor">365644</idno>
<affiliation ref="#struct-2775"></affiliation>
<affiliation ref="#struct-2904"></affiliation>
<affiliation ref="#struct-199397"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Luc</forename>
<surname>Defebvre</surname>
</persName>
<email></email>
<idno type="halauthor">365645</idno>
</author>
<editor role="depositor">
<persName>
<forename>Anny</forename>
<surname>Wartel</surname>
</persName>
<email>a-wartel@chru-lille.fr</email>
</editor>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2008-11-05 15:53:33</date>
<date type="whenModified">2008-11-05 15:53:33</date>
<date type="whenReleased">2008-11-05 15:53:33</date>
<date type="whenProduced">2008-04-30</date>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="132183">
<persName>
<forename>Anny</forename>
<surname>Wartel</surname>
</persName>
<email>a-wartel@chru-lille.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">hal-00336977</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-00336977</idno>
<idno type="halBibtex">devos:hal-00336977</idno>
<idno type="halRefHtml">Movement Disorders, Wiley, 2008, 23 (6), pp.850-7. <10.1002/mds.21966></idno>
<idno type="halRef">Movement Disorders, Wiley, 2008, 23 (6), pp.850-7. <10.1002/mds.21966></idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
<idno type="stamp" n="UNIV-LILLE1">Université des Sciences et Technologie de Lille - Lille I</idno>
<idno type="stamp" n="UNIV-LILLE2">Université du Droit et de la Santé - Lille II</idno>
<idno type="stamp" n="UNIV-VALENCIENNES">Université de Valenciennes et du Hainaut-Cambresis</idno>
<idno type="stamp" n="UNIV-LYON1">Université Claude Bernard - Lyon I</idno>
<idno type="stamp" n="RIIP_LILLE">Institut Pasteur de Lille</idno>
<idno type="stamp" n="FNCLCC" p="INSERM">UNICANCER</idno>
<idno type="stamp" n="LAMBRET" p="FNCLCC">Centre Oscar Lambret</idno>
<idno type="stamp" n="UNIV-AMU">HAL - Aix Marseille Université</idno>
</seriesStmt>
<notesStmt>
<note type="audience" n="2">International</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.</title>
<author role="aut">
<persName>
<forename type="first">David</forename>
<surname>Devos</surname>
</persName>
<idno type="halAuthorId">365640</idno>
<affiliation ref="#struct-1296"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Kathy</forename>
<surname>Dujardin</surname>
</persName>
<idno type="halAuthorId">365641</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Isabelle</forename>
<surname>Poirot</surname>
</persName>
<idno type="halAuthorId">365642</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Caroline</forename>
<forename type="middle">C.</forename>
<surname>Moreau</surname>
</persName>
<idno type="halAuthorId">113337</idno>
<affiliation ref="#struct-94723"></affiliation>
<affiliation ref="#struct-581"></affiliation>
<affiliation ref="#struct-11037"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Olivier</forename>
<surname>Cottencin</surname>
</persName>
<idno type="halAuthorId">362835</idno>
<affiliation ref="#struct-11323"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Pierre</forename>
<surname>Thomas</surname>
</persName>
<idno type="halAuthorId">165345</idno>
<affiliation ref="#struct-11323"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Alain</forename>
<surname>Destée</surname>
</persName>
<idno type="halAuthorId">365643</idno>
<affiliation ref="#struct-58976"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Regis</forename>
<surname>Bordet</surname>
</persName>
<idno type="halAuthorId">365644</idno>
<affiliation ref="#struct-2775"></affiliation>
<affiliation ref="#struct-2904"></affiliation>
<affiliation ref="#struct-199397"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Luc</forename>
<surname>Defebvre</surname>
</persName>
<idno type="halAuthorId">365645</idno>
</author>
</analytic>
<monogr>
<idno type="halJournalId" status="VALID">17211</idno>
<idno type="issn">0885-3185</idno>
<idno type="eissn">1531-8257</idno>
<title level="j">Movement Disorders</title>
<imprint>
<publisher>Wiley</publisher>
<biblScope unit="volume">23</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="pp">850-7</biblScope>
<date type="datePub">2008-04-30</date>
</imprint>
</monogr>
<idno type="doi">10.1002/mds.21966</idno>
<idno type="pubmed">18311826</idno>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="en">English</language>
</langUsage>
<textClass>
<classCode scheme="mesh">Aged</classCode>
<classCode scheme="mesh">Antidepressive Agents</classCode>
<classCode scheme="mesh">Parkinson Disease</classCode>
<classCode scheme="mesh">Placebos</classCode>
<classCode scheme="mesh">Prevalence</classCode>
<classCode scheme="mesh">Psychiatric Status Rating Scales</classCode>
<classCode scheme="mesh">Citalopram</classCode>
<classCode scheme="mesh">Depression</classCode>
<classCode scheme="mesh">Desipramine</classCode>
<classCode scheme="mesh">Double-Blind Method</classCode>
<classCode scheme="mesh">Female</classCode>
<classCode scheme="mesh">Humans</classCode>
<classCode scheme="mesh">Male</classCode>
<classCode scheme="mesh">Middle Aged</classCode>
<classCode scheme="halDomain" n="sdv.neu">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en">Depression is one of the most common psychiatric disturbances in Parkinson's disease (PD). Recent reviews have highlighted the lack of controlled trials and the ensuing difficulty in formulating recommendations for antidepressant use in PD. We sought to establish whether antidepressants provide real benefits and whether tricyclic and selective serotonin reuptake inhibitor (SSRI) antidepressants differ in their short-term efficacy, because the time to onset of therapeutic benefit remains an important criterion in depression. The short-term efficacy (after 14 and 30 days) of two antidepressants (desipramine, a predominantly noradrenergic reuptake inhibitor tricyclic and citalopram, a SSRI) was assessed in a double-blind, randomized, placebo- controlled study of 48 nondemented PD patients suffering from major depression. After 14 days, desipramine prompted an improvement in the Montgomery Asberg Depression Rating Scale (MADRS) score, compared with citalopram and placebo. Both antidepressants produced significant improvements in the MADRS score after 30 days. Mild adverse events were twice as frequent in the desipramine group as in the other groups. A predominantly noradrenergic tricyclic antidepressant induced a more intense short-term effect on parkinsonian depression than did an SSRI. However, desipramine's lower tolerability may outweigh its slight short-term clinical advantage.</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Hal/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000037 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Checkpoint/biblio.hfd -nk 000037 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Hal
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Hal:hal-00336977
   |texte=   Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024